Multiple nanorobots with single functions have been developed in recent years. Now, researchers have created a single nanorobot with multiple functions.
In medicine, too, there is no free lunch – effective therapies come with side effects. But two new studies could make lunch cheaper for patients treated with chimeric antigen receptor (CAR) T cells. Researchers at the San Raffaele Hospital in Milan, Italy, and the Memorial Sloan Kettering Cancer Center (MSKCC) have gained new insights into the causes of cytokine release syndrome (CRS) and neurotoxicity, the two most serious forms of toxicity that are associated with CAR T cells.
Researchers from the University of California at Los Angeles and Duke University have developed an implantable gel that could stimulate first blood vessel formation, and then brain regeneration, after stroke.
Call it the engineer's version of probiotics. Scientists at the Massachusetts Institute of Technology have engineered a device that combined bacteria and microelectronics to detect biological signals in the gut.
Deep brain stimulation (DBS) improved insulin sensitivity in multiple tissues in both diabetic and nondiabetic patients who were receiving DBS to treat obsessive-compulsive disorder (OCD), researchers reported in the May 23, 2018, issue of Science Translational Medicine.
Scientists from the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium and the Karolinska Institutet have mapped the effects of schizophrenia risk variants to a few specific cell types. Knowledge of the risk variants themselves has not yet led to obvious new targets for the disorder, in part because of the brain's large number of cell types.
